These findings are also in accordance with other accounts of increased proNGF in CSF from people with AD (E Counts et al., 2016), and with the altered expression of MMP-3, neuroserpin, and plasminogen reported in CSF from AD and MCI participants (Hanzel et al., 2014). This evidence concerns the gene PLG and Alzheimer disease.